F.D.A. Approves Sickle Cell Treatments, Including One That Uses CRISPR
People with the genetic disease have new opportunities to eliminate their symptoms, but the treatments come with obstacles that limit their reach.
Source: nytimes.com
Page 23 - Crispr News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Crispr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Crispr Today - Breaking & Trending Today
First CRISPR Sickle Cell Patient 'Reborn': FDA Approves Treatment
The FDA's approval of Casgevy, which uses the Nobel Prize-winning gene-editing therapy to treat patients with sicke cell disease, opens the door to many other therapies.
Source: forbes.com
FDA Approves Exagamglogene Autotemcel, First CRISPR Gene-Editing Therapy for SCD
The FDA has approved a gene-editing therapy for sickle cell disease (SCD) for the first time.
Source: ajmc.com
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most
There is no clear path for African patients to get access to the treatments, which have multimillion-dollar price tags and are highly complex to manufacture and deliver.
Source: nytimes.com
Jennifer Doudna Believes Crispr Is for Everyone
Pioneering biochemist Jennifer Doudna sat down with WIRED’s Emily Mullin to talk about the future of Crispr.
Source: wired.com